OPDIVO 10 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION

Bristol-Myers Squibb Pharma Eeig🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: f60f03ed515b7bfb
Drug Cima Aemps Name: OPDIVO 10 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION
Register Number: 1151014002IP1
Holder Company Name: Bristol-Myers Squibb Pharma Eeig
Marketing Company Name: Melyfarma S.L.
Holder Company Detail Path: /organization/bristol-myers-squibb-pharma-eeig
Authorization Date: 2021-07-01
Dosage Form: CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose: 10 mg/ml
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: Yes
Company Name: Bristol-Myers Squibb Pharma Eeig
Company Detail Path: /organization/bristol-myers-squibb-pharma-eeig

NIVOLUMAB

100 mg/dosis

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jul 1, 2021

Approval ID

f60f03ed515b7bfb

Type

Standard